Aesthetic Medical International Holdings Group (3FMA) Price & Analysis

1 Followers

3FMA Stock Chart & Stats

€0.13

<€0.01(0.84%)

At close: Jan 08 4:00 PM EST

€0.13

<€0.01(0.84%)

Day’s Range― - ―

52-Week Range€0.01 - €0.22

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

€3.46M

Enterprise Value€233.83M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta1.83

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding48,687,584

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-0.90

Price to Sales (P/S)0.03

P/FCF Ratio-0.80

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Gross Margin StrengthSustained gross margins in the mid‑40s to low‑50s indicate the core service offering retains pricing power and cost advantage. That margin buffer can absorb some SG&A volatility and supports a path to operating leverage if revenue stabilizes.

Historic Cash GenerationThe company showed the ability to convert operations into cash in 2023–2024, demonstrating an underlying business model that can generate free cash when operating performance is stable. This suggests recoverable liquidity if operational trends reverse positively.

Operational ScaleA workforce of ~1,309 indicates established operational capacity and service delivery scale in medical care facilities. Scale supports network effects, consistent service coverage, and potential to spread fixed costs over higher revenue as utilization improves.

Bears Say

Deteriorated Balance SheetRising debt alongside negative shareholders' equity materially reduces financial flexibility and increases insolvency risk. Negative equity limits the company's ability to absorb further losses, raises creditor scrutiny, and constrains strategic options over the medium term.

Cash Flow ReversalThe shift from positive to negative operating and free cash flow in 2025 increases funding pressure and raises the likelihood of external financing or asset sales. Persistent negative cash flows impair reinvestment capacity and long‑term operational stability.

Persistent Losses And Revenue DeclineWidening net losses combined with a 2025 revenue decline after prior growth signal the company has not secured durable profitable growth. Without sustained revenue recovery, margins at the operating level will remain pressured and profitability may be elusive.

3FMA FAQ

What was Aesthetic Medical International Holdings Group’s price range in the past 12 months?

Aesthetic Medical International Holdings Group lowest stock price was €0.01 and its highest was €0.22 in the past 12 months.

What is Aesthetic Medical International Holdings Group’s market cap?

Aesthetic Medical International Holdings Group’s market cap is €3.46M.

When is Aesthetic Medical International Holdings Group’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Aesthetic Medical International Holdings Group’s earnings last quarter?

Currently, no data Available

Is Aesthetic Medical International Holdings Group overvalued?

According to Wall Street analysts Aesthetic Medical International Holdings Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aesthetic Medical International Holdings Group pay dividends?

Aesthetic Medical International Holdings Group does not currently pay dividends.

What is Aesthetic Medical International Holdings Group’s EPS estimate?

Aesthetic Medical International Holdings Group’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aesthetic Medical International Holdings Group have?

Aesthetic Medical International Holdings Group has 48,687,584 shares outstanding.

What happened to Aesthetic Medical International Holdings Group’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Aesthetic Medical International Holdings Group?

Currently, no hedge funds are holding shares in DE:3FMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aesthetic Medical International Holdings Group

Aesthetic Medical International Holdings Group Ltd. engages in the provision of aesthetic medical services. It offers surgical and non-surgical treatments, cosmetic dentistry, and general healthcare services. The firm's treatments include eye surgery, rhinoplasty, breast augmentation, liposuction, laser, ultrasound, and ultraviolet light treatments. The company was founded by Zhou Peng Wu and Ding Wen Ting in 1997 and is headquartered in Shenzhen, China.